Ziganshina 2020 — Cochrane Review of Cerebrolysin for Acute Ischaemic Stroke

Cochrane Database of Systematic Reviews·July 10, 2020

Liliya E. Ziganshina, Tatyana R. Abakumova, Cochrane Stroke Group

Summary

Cochrane review concluded Cerebrolysin probably has little or no effect on all-cause death or serious adverse events in acute ischaemic stroke, with possible increase in non-fatal serious adverse events.

Study Details

Study Design

Systematic review of randomized controlled trials

Indication

Acute ischaemic stroke

Intervention

Cerebrolysin vs placebo or no treatment

Species

Human

Sample Size

1,435 subjects

Risk of Bias Assessment

Moderate-quality evidence; negative/limited benefit